RFM
ELV icon

Ranmore Fund Management’s Elevance Health ELV Stock Holding History

Ranmore Fund Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-136,600
Closed -$40M – 25
2026
Q1 		$40M Buy
136,600
+23,600
+21% +$7.76M 5.28% 12
2025
Q4 		$39.6M Buy
113,000
+19,000
+20% +$6.42M 6.8% 8
2025
Q3 		$30.4M Buy
94,000
+44,000
+88% +$13.7M 8.23% 6
2025
Q2 		$19.4M Buy
+50,000
New +$20.1M 7.75% 9

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ranmore Fund Management's ELV Position: Q2 2026 in Review

Ranmore Fund Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 136,600 shares — an estimated $40M sold.

Ranmore Fund Management first reported a position in ELV in Q2 2025 and held it in 4 quarters. The position peaked at $40M in Q1 2026. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ranmore Fund Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Ranmore Fund Management sold 136,600 Elevance Health shares in Q2 2026, an estimated $40M.
  • Ranmore Fund Management first reported a position in Elevance Health in Q2 2025 and held it in 4 quarters.
  • Ranmore Fund Management's Elevance Health position peaked at $40M in Q1 2026.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ranmore Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.